Your browser doesn't support javascript.
loading
Targeting survivin as a potential new treatment for chondrosarcoma of bone.
de Jong, Y; van Oosterwijk, J G; Kruisselbrink, A B; Briaire-de Bruijn, I H; Agrogiannis, G; Baranski, Z; Cleven, A H G; Cleton-Jansen, A-M; van de Water, B; Danen, E H J; Bovée, J V M G.
Afiliación
  • de Jong Y; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Oosterwijk JG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kruisselbrink AB; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Briaire-de Bruijn IH; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Agrogiannis G; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Baranski Z; First Department of Pathology, Department of Clinical-laboratory Studies, Athens University Medical School, Athens, Greece.
  • Cleven AH; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
  • Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • van de Water B; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Danen EH; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
  • Bovée JV; Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.
Oncogenesis ; 5: e222, 2016 May 09.
Article en En | MEDLINE | ID: mdl-27159675

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncogenesis Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncogenesis Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos